4.5 Article

FIGO Statement: Vaccination in pregnancy

Journal

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
Volume 152, Issue 2, Pages 139-143

Publisher

WILEY
DOI: 10.1002/ijgo.13456

Keywords

Best practice; Maternity care; Safe motherhood; Vaccination

Ask authors/readers for more resources

During pregnancy, influenza and Tdap vaccines are strongly recommended, with other vaccines offered based on risk factors. The FIGO Committee endorses vaccinating all pregnant women against influenza during the influenza season and preferably between the 27th and 36th weeks for Tdap.
Pregnant women and their fetuses are among the vulnerable populations that can be severely affected by communicable diseases. As such, some vaccines such as the influenza and the Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) vaccines are strongly recommended in each pregnancy, with generally safe profiles. Other vaccines can be offered based on risk factors, and only when the benefits of receiving them outweigh the risks. Development of vaccines against group B streptococcus infection and respiratory syncytial virus infection are of great importance. In this paper, the recommendations for administration of each vaccine during pregnancy are discussed. The FIGO Committee for Safe Motherhood and Newborn Health Committee endorses the recommendations to vaccinate all pregnant women against influenza during the influenza season at any time during the pregnancy and against Tdap preferably between the 27th and 36th weeks of pregnancy in each pregnancy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available